Alnylam Pharmaceuticals, Inc. has submitted a Type II variation application to the European Medicines Agency (EMA) for vutrisiran, an investigational RNA interference (RNAi) therapy aimed at treating ATTR amyloidosis with…
Personalized Nutrition Market Report 2024: Overview and Growth Projections The report titled “Personalized Nutrition Market – Types, Forms, Applications and End-Use Markets” has been released by ResearchAndMarkets.com. The global personalized…
Wolters Kluwer Health is celebrating the first anniversary of AI Labs for UpToDate® with the introduction of advanced AI capabilities aimed at enhancing clinical decision-making. This experimental initiative places health…
ByHeart Expands Distribution to Walmart, Whole Foods, and Wegmans, Boosting Retail Presence by Over 200% ByHeart, the evidence-backed infant nutrition company, has announced its expansion into Walmart, Whole Foods Market,…
Upfront Partners with athenahealth to Enhance Patient Engagement and Revenue Growth for Healthcare Providers Upfront Healthcare, a leading patient engagement technology company, has announced its partnership with athenahealth Inc. through…
eClinicalWorks’ AI Technology Enables York Primary Care to Save Over an Hour Daily on Fax Management eClinicalWorks®, the largest ambulatory cloud EHR provider, has announced that York Primary Care is…
ClearB Therapeutics Licenses Novel Saponin Adjuvant TQL-1055, to Present Hepatitis B Vaccine Data at AASLD 2024 ClearB Therapeutics, a company focused on developing therapeutic vaccines for a functional cure of…
Life Sciences Experts to Explore Global Collaboration, AI, and Clinical Trial Innovation at DIA Canada Annual Meeting The upcoming DIA Canada Annual Meeting, taking place on November 14-15 in Gatineau,…
CareSource and Nomi Health Partner to Improve Healthcare Access for Medicaid Members CareSource, a nonprofit health plan serving over 2 million members, has partnered with Nomi Health to launch a…
Komodo Health Unveils National Drug Projections for Real-Time Prescription Insights Komodo Health has launched its new product, National Drug Projections, offering a comprehensive view of prescription trends across the U.S.…
Clarametyx Biosciences Moves Forward with Phase 2a Study of CMTX-101 for Cystic Fibrosis Infections Clarametyx Biosciences, Inc. has successfully completed the Phase 1b portion of its clinical trial for CMTX-101,…
ModMed Empowers Ophthalmology Practices with Innovative Solutions at AAO 2024 ModMed® is excited to announce its participation in the American Academy of Ophthalmology (AAO) 2024 conference, taking place from October…